Skip Navigation LinksHome > September 2014 - Volume 33 - Issue 9 > Risk Factors for Critical Disease and Death from Hand, Foot...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000319
Pathogenesis and Host Response

Risk Factors for Critical Disease and Death from Hand, Foot and Mouth Disease

He, Yilin MM*†; Yang, Jianguo BM*; Zeng, Guang MM; Shen, Tao MD; Fontaine, Robert E. MD; Zhang, Lijie MD; Shi, Guoqing MM; Wang, Yulin BM§; Li, Qin BM§; Long, Jiang MM§

Collapse Box


Background: There has been a high mortality and morbidity rate of critical and fatal patients from hand, foot and mouth disease (HFMD) in China in recent. Causes for development of critical and fatal disease remain unclear.

Methods: We performed a case-control study to assess the association between use of drugs and development of critical disease and death from HFMD.

Results: We found that glucocorticoids treatment was associated with a greater incidence of severe HFMD, whereas andrographolides treatment was associated with a protective effect when they are used for treatment within 48 hours after onset or before being diagnosed as critical.

Conclusions: We recommend that glucocorticoids should not be used for mild HFMD and andrographolides should undergo clinical trials for treatment of enterovirus 71 infections.

© 2014 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.